We are live on
!
Find out more
GCM
Galibier Capital Management Portfolio holdings
AUM
$300M
1-Year Est. Return
22.03%
This Fund
S&P 500
This Quarter
Est. Return
+8.29%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
–
AUM
$425M
AUM Growth
+$113M
(+36%)
Cap. Flow
+$89.4M
Cap. Flow
% of AUM
21.02%
Top 10 Holdings %
Top 10 Hldgs %
79.58%
Holding
40
New
4
Increased
14
Reduced
10
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$18.5M |
| 2 |
GSK
GSK
|
+$18.1M |
| 3 |
Restaurant Brands International
QSR
|
+$11.6M |
| 4 |
Rogers Communications
RCI
|
+$10.7M |
| 5 |
Nutrien
NTR
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$14.4M |
| 2 |
Emerson Electric
EMR
|
+$2.4M |
| 3 |
Middleby
MIDD
|
+$1.43M |
| 4 |
Visa
V
|
+$499K |
| 5 |
Walt Disney
DIS
|
+$312K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.07% |
| 2 | Materials | 18.7% |
| 3 | Consumer Discretionary | 17.91% |
| 4 | Industrials | 12.93% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Canadian Imperial Bank of Commerce
CM
$107B
| $46.7M | 10.99% |
1,254,506
+204,192
| +19% | +$7.47M |
|
|
2
Nutrien
NTR
$32.7B
| $45.8M | 10.78% |
1,172,331
+275,237
| +31% | +$10M |
|
|
3
Restaurant Brands International
QSR
$25.1B
| $41.8M | 9.83% |
730,137
+207,581
| +40% | +$11.6M |
|
4
Manulife Financial
MFC
$72.6B
| $40.7M | 9.57% |
2,933,687
+509,126
| +21% | +$7.29M |
|
|
5
Rogers Communications
RCI
$17.7B
| $38.7M | 9.1% |
978,800
+260,538
| +36% | +$10.7M |
|
|
WCN
6
Waste Connections
WCN
$42.8B
| $34.3M | 8.08% |
331,495
+56,533
| +21% | +$5.65M |
|
|
KL
7
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $33.7M | 7.92% |
692,235
+368,923
| +114% | +$18.5M |
|
8
CGI
GIB
$13.9B
| $21.3M | 5.01% |
315,079
+69,007
| +28% | +$4.7M |
|
9
Ross Stores
ROST
$76.6B
| $18.4M | 4.32% |
196,812
+23,858
| +14% | +$2.14M |
|
|
10
GSK
GSK
$103B
| $17M | 3.99% |
+360,593
| New | +$18.1M |
|
11
Gildan
GIL
$9.25B
| $16M | 3.76% |
813,367
+172,845
| +27% | +$3.2M |
|
12
Enbridge
ENB
$124B
| $15.4M | 3.62% |
528,005
+116,528
| +28% | +$3.67M |
|
13
Scotiabank
BNS
$106B
| $14.6M | 3.44% |
353,370
+76,837
| +28% | +$3.22M |
|
|
14
Emerson Electric
EMR
$82.9B
| $12.9M | 3.03% |
196,788
-36,403
| -16% | -$2.4M |
|
15
Oshkosh
OSK
$9.67B
| $4.88M | 1.15% |
66,448
+11,892
| +22% | +$916K |
|
16
Henry Schein
HSIC
$9.74B
| $2.33M | 0.55% |
39,701
| – | – |
|
17
Fluor
FLR
$7.29B
| $1.71M | 0.4% |
193,571
| – | – |
|
18
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.45M | 0.34% |
6,810
| – | – |
|
|
PCOM
19
DELISTED
Points.com Inc. Common Shares
PCOM
| $1.41M | 0.33% |
147,454
| – | – |
|
|
20
AstraZeneca
AZN
$263B
| $1.37M | 0.32% |
12,526
-129,048
| -91% | -$14.4M |
|
21
Cisco
CSCO
$450B
| $1.24M | 0.29% |
31,516
+2,939
| +10% | +$128K |
|
22
AbbVie
ABBV
$458B
| $1.18M | 0.28% |
13,512
| – | – |
|
23
Medtronic
MDT
$107B
| $1.16M | 0.27% |
11,170
| – | – |
|
24
RTX Corp
RTX
$287B
| $1.15M | 0.27% |
+20,000
| New | +$1.22M |
|
25
Thermo Fisher Scientific
TMO
$211B
| $1.06M | 0.25% |
2,395
-450
| -16% | -$186K |
|
Similar funds
LIG
LSA
OPPS
FIBT
SFG
FW
SC
AFWM
Galibier Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Galibier Capital Management held 40 positions worth $425M, up 36% from $312M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Galibier Capital Management deployed $89.4M of net new capital in Q3 2020, opening 4 new positions and adding to 14 existing holdings. Its largest new stake was GSK: 360,593 shares worth $17M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Materials and Consumer Discretionary.
On the sell side, the largest reduction was AstraZeneca, an estimated $14.4M trimmed.
- Galibier Capital Management's largest Q3 2020 buy was GSK: 360,593 shares worth $17M.
- Galibier Capital Management added most to Kirkland Lake Gold Ltd Ordinary in Q3 2020, an estimated $18.5M increase.
- Galibier Capital Management's biggest Q3 2020 reduction was AstraZeneca, cutting an estimated $14.4M.
- Galibier Capital Management fully exited Middleby in Q3 2020, selling an estimated $1.43M.
- Galibier Capital Management's ten largest holdings make up 80% of its $425M portfolio in Q3 2020.
- Galibier Capital Management opened 4 new positions and closed 1 in Q3 2020.
- Galibier Capital Management's portfolio value rose 36% quarter-over-quarter to $425M.
Based on Galibier Capital Management's 13F filing for Q3 2020, filed 26 Oct 2020.